Osteocrin – Beyond just another bone protein?

[1]  Meriem Semache,et al.  Lipolysis and the integrated physiology of lipid energy metabolism. , 2008, Molecular genetics and metabolism.

[2]  C. Teixeira,et al.  Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. , 2008, Developmental biology.

[3]  F. Crampes,et al.  Control of lipolysis by natriuretic peptides and cyclic GMP , 2008, Trends in Endocrinology & Metabolism.

[4]  H. Kaneki,et al.  The receptor attributable to C‐type natriuretic peptide‐induced differentiation of osteoblasts is switched from type B‐ to type C‐natriuretic peptide receptor with aging , 2008, Journal of cellular biochemistry.

[5]  N. LeBrasseur,et al.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.

[6]  H. Auer,et al.  Transcriptional profiling of the megabladder mouse: A unique model of bladder dysmorphogenesis , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  C. Lanctôt,et al.  Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth* , 2007, Journal of Biological Chemistry.

[8]  M. Matsuda,et al.  Foxo1 represses expression of musclin, a skeletal muscle-derived secretory factor. , 2007, Biochemical and biophysical research communications.

[9]  T. Tsao,et al.  Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[10]  W. Wilcox,et al.  C-natriuretic peptide: an important regulator of cartilage. , 2007, Molecular genetics and metabolism.

[11]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[12]  R. Ravazzolo,et al.  Overexpression of the C‐type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation , 2007, Human mutation.

[13]  Olivier Gascuel,et al.  Identification of novel peptide hormones in the human proteome by hidden Markov model screening. , 2007, Genome research.

[14]  A. Bigard,et al.  Musclin gene expression is strongly related to fast-glycolytic phenotype. , 2007, Biochemical and biophysical research communications.

[15]  C. Ashwell,et al.  Genome-wide linkage analysis to identify chromosomal regions affecting phenotypic traits in the chicken. III. Skeletal integrity. , 2007, Poultry science.

[16]  K. Kornacker,et al.  Identification of a unique transgenic mouse line that develops megabladder, obstructive uropathy, and renal dysfunction. , 2007, Journal of the American Society of Nephrology : JASN.

[17]  R. Olney.  C-type natriuretic peptide in growth: a new paradigm. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[18]  M. Warman,et al.  Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  M. Anand-Srivastava.  Natriuretic peptide receptor-C signaling and regulation , 2005, Peptides.

[20]  S. Mundlos,et al.  Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. , 2004, American journal of human genetics.

[21]  M. Matsuda,et al.  Musclin, a Novel Skeletal Muscle-derived Secretory Factor* , 2004, Journal of Biological Chemistry.

[22]  C. Lanctôt,et al.  Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype* , 2003, Journal of Biological Chemistry.

[23]  N. Tamura,et al.  C-Type Natriuretic Peptide/Guanylate Cyclase B System in Rat Osteogenic ROB-C26 Cells and its Down-Regulation by Dexamethazone , 1999, Calcified Tissue International.

[24]  J. Jaubert,et al.  Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Itoh,et al.  C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. , 1996, Biochemical and biophysical research communications.

[26]  A. Yamaguchi,et al.  cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. , 1996, The American journal of physiology.

[27]  K. Nakao,et al.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway , 2004, Nature Medicine.

[28]  中所 英樹.  Dwarfism and early death in mice lacking C-type natriuretic peptide , 2001 .